MiR-125b also exhibited good anti-tumor effects in murine orthotopic breast cancer, which was attributed to its promotive effect on M1 polarization by targeting interferon regulatory factor 4 (IRF4) in macrophages, and suppressed tumor cells by targeting ETS proto-oncogene 1 and cyclin-J (73). This evidence concerns the gene IRF4 and breast cancer.